News


  • Featured
  • All News

08 Dec 2020

Faruqi & Faruqi, LLP, Appointed Sole Lead Counsel to Lead Allergan Securities Litigation

On December 7, 2020, United States District Court Chief Judge Colleen McMahon of the United States District Court for the Southern District of New York appointed Faruqi & Faruqi, LLP as sole lead counsel and its client DeKalb County Pension Fund ("DeKalb") ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

08 Dec 2020

$120 Million Antitrust Settlement for Direct Purchasers of Birth Control Pills Loestrin 24 Fe and Minastrin 24 Fe Receives Final Approval

On September 1, 2020, Chief Judge William E. Smith of the United States District Court for the District of Rhode Island granted final approval to a $120 million settlement of antitrust claims asserted on behalf of a certified class of direct purchasers ...

Read more

18 Nov 2020

REZA REZVANI NAMED FELLOW OF LITIGATION COUNSEL OF AMERICA

New York attorney Reza Rezvani, of the law firm Faruqi & Faruqi, LLP, has been selected as a Fellow of the Litigation Counsel of America (the "LCA"). Reza is a partner of the firm's personal injury litigation department. A 1998 graduate of Binghamton ...

Read more

04 Nov 2020

Reza Rezvani Named 2020 New York Metro Super Lawyer

Reza Rezvani has been selected to the 2020 New York Super Lawyers list. Each year, no more than five percent of the lawyers in the state are selected by the research team at Super Lawyers to receive this honor. Super Lawyers, a Thomson Reuters business, ...

Read more

12 Oct 2020

FARUQI & FARUQI, LLP FILES COMPLAINT AGAINST NINTENDO OVER SWITCH’S JOY-CON DRIFT

On October 5th, 2020, Faruqi & Faruqi filed a consumer protection and false advertising class action against Nintendo of America Inc., regarding a defect in its Switch Joy-Con gaming console controllers. The defect, also known as "Joy-Con Drift" to gamers, ...

Read more

08 Oct 2020

Faruqi & Faruqi Class Counsel in Restasis MDL. Court Certifies Direct Purchaser Settlement Class and Grants Final Approval to $51.25 Million Settlement.

In an Opinion and Order entered on October 7, 2020, the United States District Court for the Eastern District of New York (Gershon, J.) certified a settlement class of direct purchasers of brand Restasis (cyclosporine) eye drops and granted final approval ...

Features: Bradley J. Demuth

Read more

28 Sep 2020

Faruqi & Faruqi Defeats Motion To Dismiss In Investor Class Action Against Ideanomics

On September 25, 2020, Judge George B. Daniels of the Southern District of New York denied Defendant Ideanomics, Inc.'s ("Ideanomics") motion to dismiss Lead Plaintiff's amended securities class action complaint (the "Complaint"). In its order, the Court ...

Read more

22 Sep 2020

Nikola Update: Trevor Milton Resigns

Nikola Corporation ("Nikola" or "the Company") founder Trevor Milton, a named defendant in a securities class action recently filed against Nikola and certain of its executives, resigned from his position as Executive Chairman on September 20. Faruqi ...

Features: Katherine M. Lenahan

Read more

18 Sep 2020

Faruqi & Faruqi, LLP is Actively Monitoring Nikola Corporation

Nikola Corporation ("Nikola") claims to manufacturer and design battery-electric vehicles, hydrogen-electric vehicles, and hydrogen fueling stations. Trevor Milton, who has been active on social media about sustainable energy, founded Nikola in 2015. ...

Features: James M. Wilson, Jr.

Read more

15 Sep 2020

Faruqi & Faruqi Commences Class Action Against Anheuser-Busch

On September 11, 2020, Faruqi & Faruqi filed a consumer protection and false advertising class action against Anheuser-Busch for the deceptive marketing and sale of its Ritas™ Margarita, Mojito, Rosé, and Sangria beverages. The complaint alleges that ...

Read more

04 Sep 2020

Faruqi & Faruqi, LLP Recovers $120 Million Settlement in Loestrin Antitrust Litigation

Please see Order. ...

Read more

27 Aug 2020

District Court Grants Final Approval of $120 Million Settlement in Loestrin, Faruqi & Faruqi, LLP, Co-Lead Counsel

On August 27, 2020, Chief Judge William E. Smith of the District of Rhode Island granted final approval of a $120 million settlement of antitrust claims asserted on behalf of a certified class of direct purchasers of the drug Loestrin in In re Loestrin ...

Read more

26 Aug 2020

Direct Purchaser Class Certified in Zetia MDL

In an order entered on August 21, 2020 in the Zetia (Ezetimibe) Antitrust Litigation MDL, Senior United States District Judge Rebecca Beach Smith overruled Defendants' objections and adopted and approved in full United States Magistrate Judge Douglas ...

Features: Bradley J. Demuth

Read more

11 Aug 2020

Faruqi & Faruqi, LLP Secures Final Approval of a $2,083,333.33 Settlement for Revolution Lighting Techs., Inc. Investors

Faruqi & Faruqi, LLP is pleased to announce that the Court has granted final approval to the settlement in In re Revolution Lighting Techs., Inc., Securities Litigation, No. 1:19-cv-00980-JPO (S.D.N.Y.), a federal securities class action pending in the ...

Features: Katherine M. Lenahan

Read more

29 Jul 2020

Faruqi & Faruqi Announces Class Certification Victory in Third Circuit

The Third Circuit, by unanimous decision, recently affirmed class certification for direct purchasers of the opioid addiction treatment Suboxone in an antitrust case alleging that Reckitt Benckiser (now Indivior) took several actions to suppress competition ...

Read more

20 Jul 2020

G-20 Is Advised Cross-Border Payment Systems Require Public And Private Collaboration

The Bank for International Settlements' Committee on Payments and Market Infrastructures recently published a report to the G-20 detailing building blocks necessary to enhance cross-border payments. The report groups nineteen specific building blocks ...

Read more

17 Jul 2020

Faruqi & Faruqi, LLP Announces Final Approval of a Settlement on Behalf of DPW Holdings, Inc. and its Shareholders

Faruqi & Faruqi, LLP, sole lead counsel, is pleased to announce that the Court granted final approval of a settlement in Ethan Young et al. v. Milton C. Ault, III et al., No. 2:18-6587-PA (C.D. Cal.), a shareholder derivative action brought on behalf ...

Read more

08 Jul 2020

Faruqi & Faruqi, LLP Files a Class Action to Recover Unpaid Wages to NYPD Officers Working Paid Details

On June 3, 2020, Faruqi & Faruqi filed a Class and Collective Action in the United States District Court for the Southern District of New York against the City of New York, the New York City Police Department, and a number of vendors who collectively ...

Features: Innessa M. Huot

Read more

26 Jun 2020

Faruqi & Faruqi, LLP, as co-counsel, reached $51.2 million settlement In Restasis Antitrust Suit.

Allergan Inc. and Novartis AG recently reached a settlement resolving claims in New Jersey federal court that Allergan engaged in a scheme to block Shire US Inc. (which Novartis later acquired) from competing with Allergan's blockbuster drug Restasis ...

Read more

23 Jun 2020

Court Appoints Faruqi & Faruqi, LLP Lead Counsel in the Mesa Air Group Holdings Securities Litigation

On June 23, 2020, United States District Court Judge Douglas L. Rayes of the United States District Court for the District of Arizona appointed Faruqi & Faruqi, LLP as sole lead counsel and its client DeKalb County Pension Fund as sole Lead Plaintiff ...

Features: James M. Wilson, Jr.

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania